
    
      The primary aims of this clinical trial are:

        1. Determine the effectiveness of targeted learning and memory strategy remediation in
           students with sickle cell disease and cognitive deficits.

        2. Determine if there is improvement in academic achievement after targeted memory strategy
           remediation.
    
  